Advanced search
Publication Cover
Substance Use & Misuse Volume 48, 2013 - Issue 14
Submit an article Journal homepage
195
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Hepatitis C Among Injecting Drug Users Is Two Times Higher in Stockholm, Sweden than in Rotterdam, the Netherlands

Lillebil NordenDepartment of Clinical Neuroscience, Karolinska Institutet and Stockholm Addiction Centre, Stockholm, SwedenCorrespondence[email protected]
,
Maaike van VeenCenter for Infectious Disease Control, RIVM, Bilthoven, the Netherlands
,
Christer LidmanDepartment of Medicine, Karolinska Institutet, Stockholm, Sweden
,
Ivo TodorovDepartment of Psychology, Stockholm University, Stockholm, Sweden
,
Bruno GuaritaEuropean Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal
,
Mirjam KretzschmarCenter for Infectious Disease Control, RIVM, Bilthoven, the Netherlands and Julius Centre for Health Sciences and Primary Care, University Medical Centre, Utrecht, the Netherlands
&
Lucas WiessingEuropean Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal
 show all
Pages 1469-1474 | Published online: 10 Jun 2013

REFERENCE

  • Bruandet, A., Lucidarme, D., Decoster, A., Ilef, D., Harbonnier, J., Jacob, C., (2006). Incidence and risk factors of HCV infection in a cohort of intravenous drug users in the North and East of France. Rev Epidemiol Sante Publique, 54 Spec No 1:1S15–1S22.
  • de Boer, I. M., Op de Coul, E. L. M., Beuker, R. J., de Zwart, O., Al Taqatqa, W., & van de Laar, M. J. W. (2004). Trends in HIV-prevalentie en risicogedrag onder injecterende druggebruikers in Rotterdam, 1994–2002 [Trends in HIV prevalence and risk behavior among injecting drug users in Rotterdam, 1994–2002]. Nederlands Tijdschrift voor Geneeskunde, 148(47), 2325–2330.
  • EMCDDA. (2008–2009). Figure INF-6. HCV antibody prevalence among injecting drug users—studies with national and sub national coverage Statistics and Country Data; Country Overview. Retrieved October 7, 2009, from www.emcdda.europa.eu
  • EMCDDA. (2010). Statistics and Country data. Retrieved August 25, 2010, from http://www.emcdda.europa.eu
  • Gowing, L., Ali, R., & White, J. (2000). Buprenorphine for the management of opioid withdrawal. Cochrane Database of Systematic Reviews, (3):CD002025.
  • Lidman, C., Norden, L., Kåberg, M., Käll, K., Franck, J., Aleman, S., (2009). Hepatitis C infection among injecting drug users in Stockholm, Sweden: Prevalence and gender. Scandinavian Journal of Infectious Diseases, 41, 679–684.
  • Lucidarme, D., Bruandet, A., Ilef, D., Harbonnier, J., Jacob, C., Decoster, A., (2004). Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France. Epidemiology & Infection, 132(4), 699–708.
  • Maher, L., Li, J., Jalaludin, B., Chant, K. G., & Kaldor, J. M. (2007). High hepatitis C incidence in new injecting drug users: A policy failure? Australian and New Zealand Journal of Public Health, 31(1), 30–35.
  • Metzger, D. S., & Navaline, H. (2003). HIV prevention among injection drug users: The need for integrated models. Journal of Urban Health, 80(4 Suppl 3), iii59–66.
  • Ministry of Health, Welfare and Sport. (2010). EU Drugs Strategy (2005–2012) endorsed by the Council in 2004, Council Document 15074/04.
  • Norden, L., Kåberg, M., Käll, K., Franck, J., & Lidman, C. (2009). Knowledge of status and assessment of personal health consequences with hepatitis C are not enough to change risk behaviour among injecting drug users in Stockholm County, Sweden. Scandinavian Journal of Infectious Diseases, 41, 727–734.
  • Rhodes, T., Davis, M., & Judd, A. (2004). Hepatitis C and its risk management among drug injectors in London: Renewing harm reduction in the context of uncertainty. Addiction, 99(5), 621–633.
  • Schreuder, I., van der Sande, M. A., de Wit, M., Bongaerts, M., Boucher, C. A., Croes, E. A., (2010). Seroprevalence of HIV, hepatitis b, and hepatitis c among opioid drug users on methadone treatment in the Netherlands. Harm Reduction Journal, 26(7), 25.
  • Strauss, S. M., Astone-Twerell, J., Munoz-Plaza, C. E., Des Jarlais, D. C., Gwadz, M., Hagan, H., (2007). Drug treatment program patients’ hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Services Research, 7, 39.
  • Swedish Government Proposition 6:30. (2005). Swedish National Action plan on Drugs 2006–2010. Retrieved from http://www.regeringen.se
  • Turner, J., Bansi, L., Gilson, R., Gazzard, B., Walsh, J., Pillay, D., UK Collaborative HIV Cohort (UK CHIC) Study. (2009). The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomes. Journal of Viral Hepatitis, 17(8), 569–577. [Epub Oct. 13].
  • van den Berg, C., Smit, C., Van Brussel, G., Coutinho, R., & Prins, M. (2007). Amsterdam Cohort. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users. Addiction, 102(9), 1454–1462.
  • van den Hoek, J. A., van Haastrecht, H. J., & Coutinho, R. A. (1989). Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. American Journal of Public Health, 79(10), 1355–1357.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.